Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.53B
-
Number of holders
-
2197
-
Total 13F shares, excl. options
-
1.97B
-
Shares change
-
-15.6M
-
Total reported value, excl. options
-
$150B
-
Value change
-
-$1.18B
-
Put/Call ratio
-
0.92
-
Number of buys
-
823
-
Number of sells
-
-1002
-
Price
-
$76.41
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q4 2018
2,333 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q4 2018.
Merck & Co., Inc. - Common Stock (MRK) has 2,197 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.97B shares
of 2.53B outstanding shares and own 77.79% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (206M shares), BlackRock Inc. (195M shares), STATE STREET CORP (112M shares), Capital World Investors (91.8M shares), WELLINGTON MANAGEMENT GROUP LLP (65.4M shares), JPMORGAN CHASE & CO (44.2M shares), BANK OF AMERICA CORP /DE/ (43.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (40.8M shares), Bank of New York Mellon Corp (38.1M shares), and GEODE CAPITAL MANAGEMENT, LLC (34M shares).
This table shows the top 2197 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.